000 | 01808 a2200493 4500 | ||
---|---|---|---|
005 | 20250516172732.0 | ||
264 | 0 | _c20140108 | |
008 | 201401s 0 0 eng d | ||
022 | _a1098-5522 | ||
024 | 7 |
_a10.1128/IAI.00711-13 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMasin, Jiri | |
245 | 0 | 0 |
_aDifferences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the role of pore size. _h[electronic resource] |
260 |
_bInfection and immunity _cDec 2013 |
||
300 |
_a4571-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aActinobacillus pleuropneumoniae _xmetabolism |
650 | 0 | 4 |
_aAdenylate Cyclase Toxin _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBacterial Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aBordetella pertussis _xmetabolism |
650 | 0 | 4 |
_aCell Membrane _xmetabolism |
650 | 0 | 4 | _aCell Membrane Permeability |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aErythrocytes _xmetabolism |
650 | 0 | 4 |
_aHemolysin Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHemolysis |
650 | 0 | 4 | _aHexokinase |
650 | 0 | 4 |
_aLipid Bilayers _xmetabolism |
650 | 0 | 4 | _aMacrophages |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aOsmotic Pressure |
650 | 0 | 4 |
_aPyridoxal Phosphate _xanalogs & derivatives |
650 | 0 | 4 | _aRosaniline Dyes |
700 | 1 | _aFiser, Radovan | |
700 | 1 | _aLinhartova, Irena | |
700 | 1 | _aOsicka, Radim | |
700 | 1 | _aBumba, Ladislav | |
700 | 1 | _aHewlett, Erik L | |
700 | 1 | _aBenz, Roland | |
700 | 1 | _aSebo, Peter | |
773 | 0 |
_tInfection and immunity _gvol. 81 _gno. 12 _gp. 4571-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/IAI.00711-13 _zAvailable from publisher's website |
999 |
_c23131613 _d23131613 |